Devin Incerti, PhD, lead economist, Innovation and Value Initiative, discusses lessons learned and best practices that have emerged as a result of different approaches to value assessment.
Devin Incerti, PhD, lead economist, Innovation and Value Initiative, discusses lessons learned and best practices that have emerged as a result of different approaches to value assessment.
Transcript
Looking at different approaches to value assessment, what lessons learned and best practices have emerged?
One of the most common ways to do value assessment is what I would call a conventional cost-effectiveness analysis. This is used particularly in Europe, but really around the world, and they’ve been doing it for the last 40 years or so. What that means is that the methods are very well-established, we have good ways to do it, and it lets us help guide decision making. We can use it to set prices, we can use it to make coverage decisions, we can assess uncertainty. If you’re a decision maker, you might not want to just make a decision; you might want to know the uncertainty you have with that decision, and luckily those methods let us do that.
One other thing: the conventional cost-effectiveness lets us think about opportunity costs, which is, in my mind, a very important concept. If you’re introducing a new technology, it’s not free. There’s something else you could have done instead. You might have to displace a particular investment that’s already there. You might have to spend less on healthcare, or more on healthcare and less on other goods and services in the economy. And cost-effectiveness lets us do all of those things.
Frameworks for Advancing Health Equity: Youth Behavioral Health Strategy Program
September 17th 2024Chris Barton, LCSW, of Horizon Blue Cross Blue Shield of New Jersey, explores how the Youth Behavioral Health Strategy program focuses on addressing the specific needs of youth with mental health and substance use issues through a comprehensive approach.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More